SCHEMBL7735007

SCHEMBL7735007

Cc1ccc(C(=O)NCCCC(=O)O)cc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.72
POLB P06746 2/20 0.67
LMNA P02545 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.66
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
NPC1 O15118 3/20 0.59
RAB9A P51151 2/20 0.59
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
FABP4 P15090 1/20 0.57
EPHX2 P34913 1/20 0.56
KMT2A Q03164 3/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 2/20 0.54
MMP13 P45452 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13814815 0.93 MAPK1 (0.84) MAPK1POLBLMNAL3MBTL1CA1
SCHEMBL1938690 0.93 MAPK1 (0.84) MAPK1POLBLMNAL3MBTL1CA1
SCHEMBL7740826 0.91 MAPK1 (0.60) MAPK1POLBLMNAL3MBTL1CA1
SCHEMBL9717451 0.91 MAPK1 (0.85) MAPK1POLBLMNACA1CA2
SCHEMBL279993 0.89 LMNA (0.71) MAPK1POLBLMNAL3MBTL1CA1
SCHEMBL19133523 0.86 LMNA (0.71) MAPK1POLBLMNAL3MBTL1NPC1
SCHEMBL9489979 0.85 L3MBTL1 (0.86) MAPK1POLBLMNAL3MBTL1NPC1
SCHEMBL23794423 0.84 MAPK1 (0.74) MAPK1POLBLMNACA1CA2
SCHEMBL2033165 0.84 MAPK1 (0.73) MAPK1LMNACA1CA2NPC1
SCHEMBL428355 0.84 MAPK1 (1.00) MAPK1POLBLMNAL3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420427-B1 PREVENTION AND/OR TREATMENT OF RHEUMATOID DISEASES, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS, INTERSTITIAL NEPHRITIS, ARTERIOSCLEROSIS, PULMONARY EMPHYSEMA, CIRRHOSIS, CORNEA INJURY ONO PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US claimed
EP-1024134-A1 AMINOBUTANOIC ACID DERIVATIVES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-08-02 EP claimed
US-20220007684-A1 APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE Anipha Technologies Pty Ltd (AU) 2022-01-13 US disclosed
US-20220007684-A1 APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE Anipha Technologies Pty Ltd (AU) 2022-01-13 US disclosed
EP-3878287-A1 APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE Peng, Xianfeng (CN) 2021-09-15 EP disclosed
EP-3878287-A1 APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE Peng, Xianfeng (CN) 2021-09-15 EP disclosed
CN-111629602-A Application of acylated derivative of amino acid in preparation of animal feed additive 黄华成 2020-09-04 CN disclosed
US-6420427-B1 PREVENTION AND/OR TREATMENT OF RHEUMATOID DISEASES, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS, INTERSTITIAL NEPHRITIS, ARTERIOSCLEROSIS, PULMONARY EMPHYSEMA, CIRRHOSIS, CORNEA INJURY ONO PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1024134-A1 AMINOBUTANOIC ACID DERIVATIVES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-08-02 EP disclosed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US disclosed